Answers are grounded in this paper and cite their sources.
We herein report the investigation of new diphenyl ethers as Mycobacterium tuberculosis enoyl-acyl carrier protein reductase (InhA) inhibitors by structure-based drug design approach.
No takes yet. Share an insight, caveat, or question.
Inturi et al. (2016) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: